HTL Hamilton Thorne Ltd
- 1.470
- +0.060+4.26%
Hamilton Thorne Ltd News
Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55
Stifel GMP on Friday maintained its buy rating on the shares of Hamilton Thorne (HTL.TO) and its C$2.55 price target as sees no impact on the assisted reproductive technologies company from opposition
Hamilton Thorne Q1 Loss Widens Even as Sales Increase
Hamilton Thorne (HTL.TO) reported a wider first-quarter loss on higher operating expenses, despite a 16% increase in sales. The company, which services the assisted reproductive technologies and cell
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024
BEVERLY, Mass. and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to
Hamilton Thorne Ltd.'s (TSE:HTL) Largest Shareholders Are Retail Investors With 51% Ownership, Institutions Own 33%
Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment, c
Earnings Call Summary | HAMILTON THORNE LTD(HTLZF.US) Q4 2023 Earnings Conference
The following is a summary of the Hamilton Thorne Ltd. (HTLZF) Q4 2023 Earnings Call Transcript:Financial Performance:Hamilton Thorne experienced a solid financial year, with a 16% increase in annual
Hamilton Thorne's Q4 Profit Falls, Sales Rise; Provides 2024 Outlook
Hamilton Thorne Ltd. (HTL.TO), a provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies, research, and cell biology mark
Hamilton Thorne Brief: 2024 Guidance Is for a Sales Range Between US$78 and $82 Million Representing 10-15% Organic Growth; Q1 Guidance Is for a Sales Range of $19.0 to $19.4 Million
08:53 AM EDT, 03/27/2024 (MT Newswires) -- Hamilton Thorne Brief: 2024 guidance is for a sales range between US$78 and $82 million representing 10-15% organic growth; Q1 guidance is for a sales range
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2023.
Hamilton Thorne Maintained at Buy at Stifel GMP Ahead of Q4 Results; Price Target Kept at C$2.75
Stifel GMP on Tuesday reiterated its buy rating on the shares of Hamilton Thorne (HTL.TO) and its C$2.75 price target ahead of fourth-quarter results from the assisted reproductive technologies compan
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024
Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO
David Wolf to move to Executive ChairmanBEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, softw
Are Investors Undervaluing Hamilton Thorne Ltd. (TSE:HTL) By 40%?
Hamilton Thorne Ltd. Is Maintained at Buy by Stifel Nicolaus
Hamilton Thorne Ltd. Is Maintained at Buy by Stifel Nicolaus
Hamilton Thorne Ltd. Price Target Cut to C$2.20/Share From C$2.25 by Canaccord Genuity
Hamilton Thorne Ltd. Price Target Cut to C$2.20/Share From C$2.25 by Canaccord Genuity
Hamilton Thorne Brief: Q3 Sales Increased 16% Year Over Year to US$15.7 Million; Net Loss Was $785,000; After Quarter End, Company Completed Aacquisition of Gynetics
08:48 AM EST, 11/13/2023 (MT Newswires) -- Hamilton Thorne Brief: Q3 Sales increased 16% year over year to US$15.7 Million; Net loss was $785,000; After quarter end, Company Completed Aacquisition of
Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023
Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023
RETRANSMISSION: Lytham Partners Announces KOL Panels and Participating Companies for Its Fall 2023 Investor Conference
Hamilton Thorne Ltd. Price Target Raised to C$2.25/Share From C$2.15 by PI Financial
Hamilton Thorne Ltd. Price Target Raised to C$2.25/Share From C$2.15 by PI Financial
